Local News: East Tawakoni, TX 

 | 

Sign Up

 | 

Sign In

Advertisment

Isis Pharmaceuticals

Isis Pharmaceuticals News Editors

RoboBlogger

I edit this news page on Topix when no humans are available to help.

People just like you make Isis Pharmaceuticals News on Topix better every day. If you're interested in becoming an editor, apply today!

Edits History | Editor Blog

RSS icon mobile icon

Isis Pharmaceuticals News

News on Isis Pharmaceuticals continually updated from thousands of sources around the net.

13 hrs ago | Drugs.com

Isis Pharmaceuticals (Nasdaq: ISIS) Letter to Shareholders

CARLSBAD, Calif., Nov. 23 /PRNewswire-FirstCall/ -- Dear Isis Supporters and Shareholders, I would like to start by thanking you for your continuing support of Isis.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Carlsbad, CA, Pharmaceuticals

Sun Nov 22, 2009

The Motley Fool

Stocks Doing Right By Shareholders

Moreover, each company is scored relative to its market index and its industry group.

Comment?

Related Topix: Financial Markets, Corporate Governance, Law, Cell Phones, Cellphones, Electronics, Biotech, Medicine, Healthcare Industry

Sat Nov 21, 2009

Reuters

Isis cholesterol drug meets all goals of key trial

An experimental drug for patients genetically disposed to extreme high cholesterol being developed by Isis Pharmaceuticals Inc and Genzyme Corp significantly lowered cholesterol in a pivotal late-stage study, according to data presented on Tuesday.

Comment?

Related Topix: Medicine, Cholesterol, Health, Biotech, Healthcare Industry, Genzyme General

Fri Nov 20, 2009

San diego reader Blogs

Scam Diego: Isis Experimental Drug Lowers Cholesterol, but Has Damaging Side Effects

Posted November 17, 2009, 2:14 p.m. Stock of Carlsbad-based biotech Isis Pharmaceuticals plunged 17.01% today to $11.12 on good/bad news.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Thu Nov 19, 2009

TheStreet.com

Isis Cholesterol Drug Effective, but Safety a Worry: BioBuzz

An experimental drug from Isis Pharmaceuticals and Genzyme cut levels of "bad" LDL cholesterol by 25% in patients with a rare genetic disorder that causes extremely high and dangerous levels of cholesterol, according to data presented today at a medical meeting.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Genzyme General

Wed Nov 18, 2009

San Diego Union-Tribune

Isis cites promising results on new drug

Isis Pharmaceuticals reported encouraging results yesterday with a cholesterol-lowering drug but also extended the timeline for getting it on the market.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Healthcare Law, Law, HIV/AIDS, Health

Tue Nov 17, 2009

The US Market Blog

Tuesday Options Update: ISIS, DTV, SINA & XOM

Isis Pharmaceuticals Inc. Very heavy share volume is apparent at Isis, the drug-maker that, with Genzyme Corporation produces mipomersen, a drug that reduces bad cholesterol in patients genetically disposed to high levels.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Media, Computers, Search Engines, Sina

Business Wire

Public relations, press release distribution, investor relations, SEC filing

The National Association of Regulatory Utility Commi... AUSTIN, Texas-- --Lone Star Overnight , a Texas-based regional overnight package delivery company, is introducing a competitive multiple-package shipment rating option.

Comment?

Related Topix: Semiconductors, Electronics, QuickLogic, Austin, TX, Austin Metro, Biotech, Medicine, Genzyme General, Healthcare Industry

Mon Nov 16, 2009

Seeking Alpha

ISIS' Short-Term Trends Demonstrate When Technical Analysis Is Important

This is a follow up to my post, " ISIS Pharmaceuticals breaches long term support ." As many of you may know, posts from this blog are often syndicated on SeekingAlpha.com. In the case of my previous post on ISIS, I caught significant flack from the Seeking Alpha community .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Wed Nov 11, 2009

BioSpace

Altair Therapeutics Secures $17 Million Financing

Altair Therapeutics, Inc., a privately-held, biopharmaceutical company developing novel therapeutics for respiratory diseases, today announced that it has secured $17 million in a subsequent financing round.

Comment?

Related Topix: Domain Associates, Startups, Biotech, Medicine, Healthcare Industry

Sat Nov 07, 2009

American Chronicle

News and FDA Updates for Isis

A complete list of all headlines and biomedical stock developments can be found on BioMedReports.Com On 11/05/09, Isis Pharmaceuticals, Inc.

Comment?

Related Topix: Healthcare Law, Law, Biotech, Food and Drug Administration, Medicine, Healthcare Industry, VIVUS, Medical Equipment, Startups, Opinion

Fri Nov 06, 2009

GuruFocus.com

Isis Pharmaceuticals Inc. Reports Operating Results

Isis Pharmaceuticals Inc. filed Quarterly Report for the period ended 2009-09-30. Isis Pharmaceuticals Inc.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Biology

MarketWatch

Biotech Stocks: BioCryst, Isis rally; Alnylam falls

Drug stocks gained Thursday, but shares of Alnylam Pharmaceuticals fell a day after the company reported a widened third-quarter loss and said its search for research partners is taking longer than expected.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Metal, Isis, Science / Technology, BioCryst Pharmaceuticals, Financial Markets, Alnylam Pharmaceuticals

Thu Oct 29, 2009

BioSpace

Excaliard, an Isis Pharmaceuticals, Inc. Spinoff With Anti-Scarring...

Xconomy.com -- Isis Pharmaceuticals likes to talk about how its gene-silencing technology known as antisense creates so many innovative ideas for new drugs that it cana t commercialize them all itself, so it spins a few off into what CEO Stanley Crooke calls a oesatellite companies.a One of the more interesting ideas orbiting around Isis in ...

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Wed Oct 28, 2009

Medical News

United States Patent and Trademark Office allows a patent application within a Esaua patent family

Regulus Therapeutics Inc., founded by Alnylam Pharmaceuticals, Inc. , and Isis Pharmaceuticals, Inc.

Comment?

Related Topix: Patent / Trademark Law, Law, Biotech, Alnylam Pharmaceuticals, Medicine, Healthcare Industry

Sun Oct 25, 2009

Barron's

Two Top Ideas in Biotech

OUR TOP TWO IDEAS in the biotech sector remain Amgen and Isis Pharmaceuticals ; recent weakness, strong earnings from Amgen, and positive clinical data from Isis strengthen our enthusiasm for these stocks.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Amgen, Financial Markets, Onyx Pharmaceuticals, Genzyme General, ImmunoGen

Fri Oct 23, 2009

Zacks Analyst Blog

Isis Diabetes Drug Shows Promise

Earlier this week, Isis Pharmaceuticals, Inc. reported positive top-line results on its type II diabetes candidate, ISIS-113715. Results from the phase II study showed consistent and statistically significant reductions in multiple short and intermediate measures of glucose control.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Diabetes, Health

Thu Oct 22, 2009

Pharmaceutical Online

Isis Pharmaceuticals Reports Positive Phase 2 Data For ISIS...

Isis Pharmaceuticals, Inc. today announced positive top-line results from a Phase 2 study evaluating the safety and efficacy of ISIS 113715 in patients with type 2 diabetes.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Diabetes, Health, Insulin (generic), Humulin, Novolin, Medication, Henry, MD, Fasting

Mon Oct 05, 2009

The Biotech Stock Blog

Isis Pharma No Longer Paints a Profoundly Bullish Picture

I highlighted Isis Pharmaceuticals a few weeks ago believing that a sell-off causing a price decline from $19 to $16/share was a prime opportunity to buy a potential high-growth business.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Thu Oct 01, 2009

Barron's

Biotechs That Could Rebound

FOLLOWING RECENT profit-taking, we are adding Onyx Pharmaceuticals to our biotechnology trading list.

Comment?

Related Topix: Biotech, Medicine, Onyx Pharmaceuticals, Healthcare Industry, Startups, BioMarin Pharmaceutical, Amgen, ImmunoGen

East Tawakoni Jobs

Also on Topix